Related by context. Frequent words. (Click for all words.) 65 active comparator 64 alvimopan 62 TELCYTA 62 azacitidine 62 REMICADE ® 62 Phase 2a trial 62 double blinded placebo 61 LIALDA 61 tocilizumab 61 ponatinib 61 Zerenex 61 serum phosphorus 61 glatiramer acetate 61 peginterferon 61 TORISEL 60 PROMACTA 60 Jevtana 60 Cimzia R 60 sitagliptin 60 methylnaltrexone 60 NUVIGIL 60 thymalfasin 60 bazedoxifene 60 Phenoptin 60 bifeprunox 60 refractory Hodgkin lymphoma 60 VPRIV 60 Torisel 60 SinuNase 60 placebo controlled clinical 60 noninferiority 59 tanespimycin 59 abatacept 59 aflibercept 59 placebo controlled studies 59 octreotide 59 BLA submission 59 tipranavir 59 #mg dose [003] 59 Phase 2b study 59 Ostarine 59 decitabine 59 phosphate binders 59 SILENOR TM 59 adalimumab 59 temsirolimus 59 severe renal impairment 59 JANUVIA 58 CoFactor 58 biologic therapy 58 phase 2a 58 achieved statistical significance 58 SEROQUEL XR 58 NOXAFIL 58 lamotrigine 58 pramlintide 58 Phase 2a clinical 58 6R BH4 58 DR Cysteamine 58 muraglitazar 58 BAY #-# 58 TOCOSOL Paclitaxel 58 placebo controlled randomized 58 Asentar 58 rHuPH# 58 dose cohorts 58 PegIntron 58 diabetic neuropathic pain 58 composite endpoint 58 Icatibant 58 Intermezzo R 58 peginterferon alfa 2b 58 mg dose 58 daclizumab 58 pharmacokinetic studies 58 nitazoxanide 58 Arixtra 58 vandetanib 57 STELARA 57 PhosLo 57 Phase IIa trial 57 randomized controlled clinical trials 57 ABILIFY 57 Topiramate 57 romidepsin 57 interferon alfa 57 Telcyta 57 rotigotine 57 Avastin bevacizumab 57 topical formulation 57 Empatic 57 mg kg dose 57 Combination therapy 57 secondary efficacy endpoints 57 Welchol 57 phase IIb 57 mg doses 57 Board DSMB 57 Adlea 57 entecavir 57 tesmilifene